ABT-751
- Generic Name
- ABT-751
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H17N3O4S
- CAS Number
- 141430-65-1
- Unique Ingredient Identifier
- WDT5V5OB9F
- Background
ABT-751 has been investigated for the treatment of Lung Cancer, Non-Small Cell Lung Cancer, and Non-Small-Cell Lung Cancer.
- Associated Conditions
- -
- Associated Therapies
- -
Study of ABT-751 in Patients With Refractory Hematologic Malignancies
Phase 1
Completed
- Conditions
- First Posted Date
- 2002-10-09
- Last Posted Date
- 2018-10-31
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 32
- Registration Number
- NCT00047489
- Locations
- 🇺🇸
The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath